Artículo
Emergence of ceftazidime/avibactam resistance in KPC-8–producing Klebsiella pneumoniae in South America
García, J.; Nastro, Marcela; Cejas, Daniela
; Santana, G.; Mancino, M.B.; Hidalgo, M.; Maccallini, G.; Vay, C.; Radice, Marcela Alejandra
; Dabos, L.; Famiglietti, Angela María Rosa; Rodríguez, H.
![Icon](/themes/CONICETDigital/images/conicet.png)
![Icon](/themes/CONICETDigital/images/conicet.png)
Fecha de publicación:
09/2020
Editorial:
Wiley Blackwell Publishing, Inc
Revista:
Clinical Microbiology And Infection
ISSN:
1198-743X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Klebsiella pneumoniae is one of the so-called ESKAPE pathogens. These organisms are the main cause of nosocomial infections worldwide, causing life-threatening infections amongst critically ill and immunocompromised individuals. They are characterized by drug resistance mechanisms. Klebsiella pneumoniae carbapenemase (KPC)-producing isolates display resistance to multiple antimicrobial agents, usually including last-resort alternative options, leading to an urgent need to develop new drugs or combinations. In Argentina sequence type (ST) 258 harbouring bla KPC-2 emerged in 2010 and remained prevalent until the last few years, when the emergence of different STs such as ST25, ST11 and ST307 appeared likely to change the local epidemiology.
Palabras clave:
Klebsiella pneumoniae
,
KPC-8
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(OCA HOUSSAY)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Citación
García, J.; Nastro, Marcela; Cejas, Daniela; Santana, G.; Mancino, M.B.; et al.; Emergence of ceftazidime/avibactam resistance in KPC-8–producing Klebsiella pneumoniae in South America; Wiley Blackwell Publishing, Inc; Clinical Microbiology And Infection; 26; 9; 9-2020; 1264-1265
Compartir
Altmétricas